Advanced Esophageal Adenocarcinoma
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB09035 | Nivolumab | A PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB09035 | Nivolumab | Programmed cell death protein 1 | target |
| DB09035 | Nivolumab | Programmed cell death 1 ligand 1 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00958 | Carboplatin | 1 | Recruiting | 1 |
| DB01229 | Paclitaxel | 1 | Recruiting | 1 |
| DB18672 | Suratadenoturev | 1 | Recruiting | 1 |
| DB06599 | Lexatumumab | 2 / 3 | Not Yet Recruiting | 1 |
| DB09035 | Nivolumab | 2 / 3 | Not Yet Recruiting | 1 |
| DB01229 | Paclitaxel | 2 / 3 | Not Yet Recruiting | 1 |
| DB05578 | Ramucirumab | 2 / 3 | Not Yet Recruiting | 1 |
| DB00544 | Fluorouracil | 3 | Recruiting | 1 |
| DB00762 | Irinotecan | 3 | Recruiting | 1 |
| DB00650 | Leucovorin | 3 | Recruiting | 1 |
| DB09035 | Nivolumab | 3 | Recruiting | 1 |
| DB00526 | Oxaliplatin | 3 | Recruiting | 1 |